NEW YORK (GenomeWeb News) – Cepheid said this week that it released an improved Xpert BCR-ABL Monitor test as a CE IVD product in the European Union. The firm said that the new test, which is used to monitor patients with chronic myelogenous leukemia, detects BCR-ABL chromosomal translocation in about 2 hours as compared to 2.5 hours for the original product release.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.